	Ebitda		日
Acadia Pharmaceuticals	USD 35.76M	447K	2025-09
Adma Biologics	USD 73.59M	14.85M	2025-12
ALKERMES	USD 100.31M	21.24M	2025-12
Alterity Therapeutics Limited	AUD -7.72M	2.99M	2023-06
AstraZeneca	USD 5.23B	272M	2025-09
BioCryst Pharmaceuticals	USD 51.7M	30.14M	2025-09
Bristol-Myers Squibb	USD 4.24B	967M	2025-09
Cipla	INR 12.55B	6.4B	2025-12
Clal Biotechnology	ILS -5.3M	2.09M	2022-12
Compugen	USD -7.89M	536K	2025-09
CSL	USD 3.13B	1.17B	2025-12
Eli Lilly	USD 7.88B	378.1M	2025-09
Esperion Therapeutics	USD -9.93M	24.99M	2025-09
GlaxoSmithKline	GBP 3.36B	179M	2025-09
Grifols	EUR 482.04M	7.04M	2025-09
Halozyme Therapeutics	USD 21.9M	226.34M	2025-12
Ionis Pharmaceuticals	USD -157.12M	307.36M	2025-09
J&J	USD 9.52B	389M	2025-09
Merck	USD 8.39B	1.97B	2025-09
Minerva Neurosciences	USD -4.36M	1.71M	2024-09
Neurocrine Biosciences	USD 218.4M	28.3M	2025-12
Novartis	USD 4.77B	1.11B	2025-12
Novavax	USD 19.36M	190.79M	2025-12
Pfizer	USD 6.08B	351M	2025-09
Roche Holding	CHF 12.68B	2.36B	2024-06
Sanofi	EUR 4.84B	2.95B	2025-09
Takeda	JPY 448.13B	173.98B	2025-12
Vanda Pharmaceuticals	USD -8.31M	2.37M	2024-12